PILOT
831175
XINGANJIANG
873167
Beijing Highlander Digital Technology
300065
4
Xiamen Hongxin Electronics Technology Group Inc.
300657
5
Shijihengtong Technology
301428
US Stock MarketDetailed Quotes
ASND Ascendis Pharma A/S
- 144.080
- +1.590+1.12%
Close Feb 14 16:00 ET
- 144.080
- 0.0000.00%
Post 17:04 ET
8.62BMarket Cap-21.03P/E (TTM)
146.905High141.822Low551.28KVolume142.850Open142.490Pre Close79.42MTurnover0.93%Turnover RatioLossP/E (Static)59.84MShares161.00052wk High-77.75P/B8.56BFloat Cap111.09052wk Low--Dividend TTM59.40MShs Float183.980Historical High--Div YieldTTM3.57%Amplitude11.920Historical Low144.055Avg Price1Lot Size
Ascendis Pharma A/S News
Ascendis Pharma A/S | 144: Notice of proposed sale of securities pursuant to Rule 144
Ascendis Pharma A/S | 144: Notice of proposed sale of securities pursuant to Rule 144
Ascendis Pharma A/S | 144: Notice of proposed sale of securities pursuant to Rule 144
Ascendis Pharma A/S | 144: Notice of proposed sale of securities pursuant to Rule 144
Ascendis Pharma A/S | 144: Notice of proposed sale of securities pursuant to Rule 144
Ascendis Pharma A/S | 144: Notice of proposed sale of securities pursuant to Rule 144
Ascendis Pharma A/S | 144: Notice of proposed sale of securities pursuant to Rule 144
Ascendis Pharma A/S | 144: Notice of proposed sale of securities pursuant to Rule 144
Ascendis Pharma A/S | 144: Notice of proposed sale of securities pursuant to Rule 144
Ascendis Pharma A/S | 424B5: Prospectus
Ascendis Pharma A/S | 424B5: Prospectus
Ascendis Pharma A/S | F-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
Ascendis Pharma A/S | 144: Notice of proposed sale of securities pursuant to Rule 144
Ascendis Pharma A/S | 144: Notice of proposed sale of securities pursuant to Rule 144
Ascendis Pharma A/S | 144: Notice of proposed sale of securities pursuant to Rule 144
Ascendis Pharma A/S | 144: Notice of proposed sale of securities pursuant to Rule 144
Ascendis Pharma A/S | 144: Notice of proposed sale of securities pursuant to Rule 144
Ascendis Pharma A/S | 144: Notice of proposed sale of securities pursuant to Rule 144
Ascendis Pharma A/S | 144: Notice of proposed sale of securities pursuant to Rule 144
Ascendis Pharma A/S | 144: Notice of proposed sale of securities pursuant to Rule 144
Trending Stocks
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum
Moo Earnings
Jan 24 10:26
TSLA earnings preview: Grab rewards by guessing the opening price!